C102H145BrClN31O10S3 — CID 161029780
2-bromoacetonitrile;tert-butyl N-[4-(dimethylamino)pyridin-1-ium-1-yl]sulfonylcarbamate;tert-butyl N-[[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methylsulfamoyl]carbamate;4-(1,4-diazepan-1-yl)-6,7-dimethylquinazoline;2-[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]acetonitrile;[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methanamine;6,7-dimethyl-4-[4-[(sulfamoylamino)methyl]-1,4-diazepan-1-yl]quinazoline;prop-2-enenitrile;chloride (PubChem CID 161029780) has the molecular formula C102H145BrClN31O10S3 and a molecular weight of 2177.05 g/mol. Its IUPAC name is 2-bromoacetonitrile;tert-butyl N-[4-(dimethylamino)pyridin-1-ium-1-yl]sulfonylcarbamate;tert-butyl N-[[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methylsulfamoyl]carbamate;4-(1,4-diazepan-1-yl)-6,7-dimethylquinazoline;2-[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]acetonitrile;[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methanamine;6,7-dimethyl-4-[4-[(sulfamoylamino)methyl]-1,4-diazepan-1-yl]quinazoline;prop-2-enenitrile;chloride.
| Compound Name | 2-bromoacetonitrile;tert-butyl N-[4-(dimethylamino)pyridin-1-ium-1-yl]sulfonylcarbamate;tert-butyl N-[[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methylsulfamoyl]carbamate;4-(1,4-diazepan-1-yl)-6,7-dimethylquinazoline;2-[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]acetonitrile;[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methanamine;6,7-dimethyl-4-[4-[(sulfamoylamino)methyl]-1,4-diazepan-1-yl]quinazoline;prop-2-enenitrile;chloride |
|---|---|
| PubChem CID | 161029780 |
| Molecular Formula | C102H145BrClN31O10S3 |
| Molecular Weight | 2177.05 g/mol |
| Exact Mass | 2173.98 |
| IUPAC Name | 2-bromoacetonitrile;tert-butyl N-[4-(dimethylamino)pyridin-1-ium-1-yl]sulfonylcarbamate;tert-butyl N-[[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methylsulfamoyl]carbamate;4-(1,4-diazepan-1-yl)-6,7-dimethylquinazoline;2-[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]acetonitrile;[4-(6,7-dimethylquinazolin-4-yl)-1,4-diazepan-1-yl]methanamine;6,7-dimethyl-4-[4-[(sulfamoylamino)methyl]-1,4-diazepan-1-yl]quinazoline;prop-2-enenitrile;chloride |
| SMILES | C=CC#N.CN(C)c1cc[n+](S(=O)(=O)NC(=O)OC(C)(C)C)cc1.Cc1cc2ncnc(N3CCCN(CC#N)CC3)c2cc1C.Cc1cc2ncnc(N3CCCN(CN)CC3)c2cc1C.Cc1cc2ncnc(N3CCCN(CNS(=O)(=O)NC(=O)OC(C)(C)C)CC3)c2cc1C.Cc1cc2ncnc(N3CCCN(CNS(N)(=O)=O)CC3)c2cc1C.Cc1cc2ncnc(N3CCCNCC3)c2cc1C.N#CCBr.[Cl-] |
| InChI | InChI=1S/C21H32N6O4S.C17H21N5.C16H24N6O2S.C16H23N5.C15H20N4.C12H19N3O4S.C3H3N.C2H2BrN.ClH/c1-15-11-17-18(12-16(15)2)22-13-23-19(17)27-8-6-7-26(9-10-27)14-24-32(29,30)25-20(28)31-21(3,4)5;1-13-10-15-16(11-14(13)2)19-12-20-17(15)22-6-3-5-21(7-4-18)8-9-22;1-12-8-14-15(9-13(12)2)18-10-19-16(14)22-5-3-4-21(6-7-22)11-20-25(17,23)24;1-12-8-14-15(9-13(12)2)18-11-19-16(14)21-5-3-4-20(10-17)6-7-21;1-11-8-13-14(9-12(11)2)17-10-18-15(13)19-6-3-4-16-5-7-19;1-12(2,3)19-11(16)13-20(17,18)15-8-6-10(7-9-15)14(4)5;1-2-3-4;3-1-2-4;/h11-13,24H,6-10,14H2,1-5H3,(H,25,28);10-12H,3,5-9H2,1-2H3;8-10,20H,3-7,11H2,1-2H3,(H2,17,23,24);8-9,11H,3-7,10,17H2,1-2H3;8-10,16H,3-7H2,1-2H3;6-9H,1-5H3;2H,1H2;1H2;1H |
| InChIKey | OKVIGIGORQHJRL-UHFFFAOYSA-N |
| XLogP | 7.85 |
| TPSA | 503.76 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 148 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2177.05 |
| LogP ≤ 5 | 7.85 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 35 |
| Structural Alerts | {'alert_name': 'acyl_het_A(9)', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}, {'alert_name': 'cyanamide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|